APO RESEARCH · REPORT
Sodium Hyaluronate Eye Drops
Sodium hyaluronate eye drops are also known as 'artificial tears'. They are used to relieve eye dryness and soreness.
Product & engineering
Understand the product.
Sodium hyaluronate eye drops are also known as 'artificial tears'. They are used to relieve eye dryness and soreness.
Selected research
Industry Growth & Trends
Global Sodium Hyaluronate Eye Drops Industry Growth and Trends Forecast to 2032
Market perspective
Sodium hyaluronate eye drops are also known as 'artificial tears'. They are used to relieve eye dryness and soreness.
Global Sodium Hyaluronate Eye Drops key players include URSAPHARM, Santen, Bayer Inc., Bausch & Lomb, Johnson & Johnson, etc. Global top five manufacturers hold a share about 40%.
Asia-Pacific is the largest market, with a share over 45%, followed by North America and Europe, both have a share over 35 percent.
Read the full market overview
In terms of product, 0.10% is the largest segment, with a share about 40%. And in terms of application, the largest application is Dry Eye, followed by Rewetting.
Report Scope
This report provides a structured, data-driven view of the global Sodium Hyaluronate Eye Drops market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Sodium Hyaluronate Eye Drops market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sodium Hyaluronate Eye Drops market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant toSodium Hyaluronate Eye Drops.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Sodium Hyaluronate Eye Drops market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Sodium Hyaluronate Eye Drops Market by Company
URSAPHARM Arzneimittel GmbH
Santen
Bayer Inc.
Bausch & Lomb
Johnson & Johnson
The United Laboratories
Alcon
Novax Pharma
Rohto
Thea Pharmaceuticals
Scope Ophthalmics Ltd
Prestige Consumer Healthcare
Medicom Healthcare Ltd
Altacor
Optrex
Sodium Hyaluronate Eye Drops Segment by Type
0.001
0.0015
0.003
Others
Sodium Hyaluronate Eye Drops Segment by Application
Dry Eye
Rewetting
Others
Sodium Hyaluronate Eye Drops Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Hyaluronate Eye Drops market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sodium Hyaluronate Eye Drops and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Hyaluronate Eye Drops.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sodium Hyaluronate Eye Drops manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Sodium Hyaluronate Eye Drops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.001
- 0.0015
- 0.003
- Others
Applications
- Dry Eye
- Rewetting
- Others
Companies covered
- URSAPHARM Arzneimittel GmbH
- Santen
- Bayer Inc.
- Bausch & Lomb
- Johnson & Johnson
- The United Laboratories
- Alcon
- Novax Pharma
- Rohto
- Thea Pharmaceuticals
- Scope Ophthalmics Ltd
- Prestige Consumer Healthcare
- Medicom Healthcare Ltd
- Altacor
- Optrex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Sodium Hyaluronate Eye Drops Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Sodium Hyaluronate Eye Drops Sales Estimates and Forecasts (2021-2032)
- 1.3 Sodium Hyaluronate Eye Drops Market by Type
- 1.3.1 0.001
- 1.3.2 0.0015
- 1.3.3 0.003
- 1.3.4 Others
- 1.4 Global Sodium Hyaluronate Eye Drops Market Size by Type
- 1.4.1 Global Sodium Hyaluronate Eye Drops Market Size Overview by Type (2021-2032)
- 1.4.2 Global Sodium Hyaluronate Eye Drops Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Sodium Hyaluronate Eye Drops Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Sodium Hyaluronate Eye Drops Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Sodium Hyaluronate Eye Drops Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Sodium Hyaluronate Eye Drops Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Sodium Hyaluronate Eye Drops Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Sodium Hyaluronate Eye Drops Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Sodium Hyaluronate Eye Drops Industry Trends
- 2.2 Sodium Hyaluronate Eye Drops Industry Drivers
- 2.3 Sodium Hyaluronate Eye Drops Industry Opportunities and Challenges
- 2.4 Sodium Hyaluronate Eye Drops Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Sodium Hyaluronate Eye Drops Revenue (2021-2026)
- 3.2 Global Top Players by Sodium Hyaluronate Eye Drops Sales (2021-2026)
- 3.3 Global Top Players by Sodium Hyaluronate Eye Drops Price (2021-2026)
- 3.4 Global Sodium Hyaluronate Eye Drops Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sodium Hyaluronate Eye Drops Major Company Production Sites & Headquarters
- 3.6 Global Sodium Hyaluronate Eye Drops Company, Product Type & Application
- 3.7 Global Sodium Hyaluronate Eye Drops Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sodium Hyaluronate Eye Drops Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sodium Hyaluronate Eye Drops Players Market Share by Revenue in 2025
- 3.8.3 2025 Sodium Hyaluronate Eye Drops Tier 1, Tier 2, and Tier 3
4 Sodium Hyaluronate Eye Drops Regional Status and Outlook
- 4.1 Global Sodium Hyaluronate Eye Drops Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Sodium Hyaluronate Eye Drops Historic Market Size by Region
- 4.2.1 Global Sodium Hyaluronate Eye Drops Sales in Volume by Region (2021-2026)
- 4.2.2 Global Sodium Hyaluronate Eye Drops Sales in Value by Region (2021-2026)
- 4.2.3 Global Sodium Hyaluronate Eye Drops Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Sodium Hyaluronate Eye Drops Forecasted Market Size by Region
- 4.3.1 Global Sodium Hyaluronate Eye Drops Sales in Volume by Region (2027-2032)
- 4.3.2 Global Sodium Hyaluronate Eye Drops Sales in Value by Region (2027-2032)
- 4.3.3 Global Sodium Hyaluronate Eye Drops Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sodium Hyaluronate Eye Drops by Application
- 5.1 Sodium Hyaluronate Eye Drops Market by Application
- 5.1.1 Dry Eye
- 5.1.2 Rewetting
- 5.1.3 Others
- 5.2 Global Sodium Hyaluronate Eye Drops Market Size by Application
- 5.2.1 Global Sodium Hyaluronate Eye Drops Market Size Overview by Application (2021-2032)
- 5.2.2 Global Sodium Hyaluronate Eye Drops Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Sodium Hyaluronate Eye Drops Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Sodium Hyaluronate Eye Drops Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Sodium Hyaluronate Eye Drops Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Sodium Hyaluronate Eye Drops Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Sodium Hyaluronate Eye Drops Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Sodium Hyaluronate Eye Drops Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 URSAPHARM Arzneimittel GmbH
- 6.1.1 URSAPHARM Arzneimittel GmbH Company Information
- 6.1.2 URSAPHARM Arzneimittel GmbH Business Overview
- 6.1.3 URSAPHARM Arzneimittel GmbH Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 URSAPHARM Arzneimittel GmbH Sodium Hyaluronate Eye Drops Product Portfolio
- 6.1.5 URSAPHARM Arzneimittel GmbH Recent Developments
- 6.2 Santen
- 6.2.1 Santen Company Information
- 6.2.2 Santen Business Overview
- 6.2.3 Santen Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Santen Sodium Hyaluronate Eye Drops Product Portfolio
- 6.2.5 Santen Recent Developments
- 6.3 Bayer Inc.
- 6.3.1 Bayer Inc. Company Information
- 6.3.2 Bayer Inc. Business Overview
- 6.3.3 Bayer Inc. Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bayer Inc. Sodium Hyaluronate Eye Drops Product Portfolio
- 6.3.5 Bayer Inc. Recent Developments
- 6.4 Bausch & Lomb
- 6.4.1 Bausch & Lomb Company Information
- 6.4.2 Bausch & Lomb Business Overview
- 6.4.3 Bausch & Lomb Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Bausch & Lomb Sodium Hyaluronate Eye Drops Product Portfolio
- 6.4.5 Bausch & Lomb Recent Developments
- 6.5 Johnson & Johnson
- 6.5.1 Johnson & Johnson Company Information
- 6.5.2 Johnson & Johnson Business Overview
- 6.5.3 Johnson & Johnson Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Johnson & Johnson Sodium Hyaluronate Eye Drops Product Portfolio
- 6.5.5 Johnson & Johnson Recent Developments
- 6.6 The United Laboratories
- 6.6.1 The United Laboratories Company Information
- 6.6.2 The United Laboratories Business Overview
- 6.6.3 The United Laboratories Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 The United Laboratories Sodium Hyaluronate Eye Drops Product Portfolio
- 6.6.5 The United Laboratories Recent Developments
- 6.7 Alcon
- 6.7.1 Alcon Company Information
- 6.7.2 Alcon Business Overview
- 6.7.3 Alcon Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Alcon Sodium Hyaluronate Eye Drops Product Portfolio
- 6.7.5 Alcon Recent Developments
- 6.8 Novax Pharma
- 6.8.1 Novax Pharma Company Information
- 6.8.2 Novax Pharma Business Overview
- 6.8.3 Novax Pharma Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Novax Pharma Sodium Hyaluronate Eye Drops Product Portfolio
- 6.8.5 Novax Pharma Recent Developments
- 6.9 Rohto
- 6.9.1 Rohto Company Information
- 6.9.2 Rohto Business Overview
- 6.9.3 Rohto Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Rohto Sodium Hyaluronate Eye Drops Product Portfolio
- 6.9.5 Rohto Recent Developments
- 6.10 Thea Pharmaceuticals
- 6.10.1 Thea Pharmaceuticals Company Information
- 6.10.2 Thea Pharmaceuticals Business Overview
- 6.10.3 Thea Pharmaceuticals Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Thea Pharmaceuticals Sodium Hyaluronate Eye Drops Product Portfolio
- 6.10.5 Thea Pharmaceuticals Recent Developments
- 6.11 Scope Ophthalmics Ltd
- 6.11.1 Scope Ophthalmics Ltd Company Information
- 6.11.2 Scope Ophthalmics Ltd Business Overview
- 6.11.3 Scope Ophthalmics Ltd Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Scope Ophthalmics Ltd Sodium Hyaluronate Eye Drops Product Portfolio
- 6.11.5 Scope Ophthalmics Ltd Recent Developments
- 6.12 Prestige Consumer Healthcare
- 6.12.1 Prestige Consumer Healthcare Company Information
- 6.12.2 Prestige Consumer Healthcare Business Overview
- 6.12.3 Prestige Consumer Healthcare Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Prestige Consumer Healthcare Sodium Hyaluronate Eye Drops Product Portfolio
- 6.12.5 Prestige Consumer Healthcare Recent Developments
- 6.13 Medicom Healthcare Ltd
- 6.13.1 Medicom Healthcare Ltd Company Information
- 6.13.2 Medicom Healthcare Ltd Business Overview
- 6.13.3 Medicom Healthcare Ltd Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Medicom Healthcare Ltd Sodium Hyaluronate Eye Drops Product Portfolio
- 6.13.5 Medicom Healthcare Ltd Recent Developments
- 6.14 Altacor
- 6.14.1 Altacor Company Information
- 6.14.2 Altacor Business Overview
- 6.14.3 Altacor Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Altacor Sodium Hyaluronate Eye Drops Product Portfolio
- 6.14.5 Altacor Recent Developments
- 6.15 Optrex
- 6.15.1 Optrex Company Information
- 6.15.2 Optrex Business Overview
- 6.15.3 Optrex Sodium Hyaluronate Eye Drops Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Optrex Sodium Hyaluronate Eye Drops Product Portfolio
- 6.15.5 Optrex Recent Developments
7 North America by Country
- 7.1 North America Sodium Hyaluronate Eye Drops Sales by Country
- 7.1.1 North America Sodium Hyaluronate Eye Drops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Sodium Hyaluronate Eye Drops Sales by Country (2021-2026)
- 7.1.3 North America Sodium Hyaluronate Eye Drops Sales Forecast by Country (2027-2032)
- 7.2 North America Sodium Hyaluronate Eye Drops Market Size by Country
- 7.2.1 North America Sodium Hyaluronate Eye Drops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Sodium Hyaluronate Eye Drops Market Size by Country (2021-2026)
- 7.2.3 North America Sodium Hyaluronate Eye Drops Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Sodium Hyaluronate Eye Drops Sales by Country
- 8.1.1 Europe Sodium Hyaluronate Eye Drops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Sodium Hyaluronate Eye Drops Sales by Country (2021-2026)
- 8.1.3 Europe Sodium Hyaluronate Eye Drops Sales Forecast by Country (2027-2032)
- 8.2 Europe Sodium Hyaluronate Eye Drops Market Size by Country
- 8.2.1 Europe Sodium Hyaluronate Eye Drops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Sodium Hyaluronate Eye Drops Market Size by Country (2021-2026)
- 8.2.3 Europe Sodium Hyaluronate Eye Drops Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Sodium Hyaluronate Eye Drops Sales by Country
- 9.1.1 Asia-Pacific Sodium Hyaluronate Eye Drops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Sodium Hyaluronate Eye Drops Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Sodium Hyaluronate Eye Drops Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Sodium Hyaluronate Eye Drops Market Size by Country
- 9.2.1 Asia-Pacific Sodium Hyaluronate Eye Drops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Sodium Hyaluronate Eye Drops Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Sodium Hyaluronate Eye Drops Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Sodium Hyaluronate Eye Drops Sales by Country
- 10.1.1 South America Sodium Hyaluronate Eye Drops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Sodium Hyaluronate Eye Drops Sales by Country (2021-2026)
- 10.1.3 South America Sodium Hyaluronate Eye Drops Sales Forecast by Country (2027-2032)
- 10.2 South America Sodium Hyaluronate Eye Drops Market Size by Country
- 10.2.1 South America Sodium Hyaluronate Eye Drops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Sodium Hyaluronate Eye Drops Market Size by Country (2021-2026)
- 10.2.3 South America Sodium Hyaluronate Eye Drops Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Sodium Hyaluronate Eye Drops Sales by Country
- 11.1.1 Middle East and Africa Sodium Hyaluronate Eye Drops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Sodium Hyaluronate Eye Drops Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Sodium Hyaluronate Eye Drops Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Sodium Hyaluronate Eye Drops Market Size by Country
- 11.2.1 Middle East and Africa Sodium Hyaluronate Eye Drops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Sodium Hyaluronate Eye Drops Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Sodium Hyaluronate Eye Drops Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Sodium Hyaluronate Eye Drops Value Chain Analysis
- 12.1.1 Sodium Hyaluronate Eye Drops Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Sodium Hyaluronate Eye Drops Production Mode & Process
- 12.2 Sodium Hyaluronate Eye Drops Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Sodium Hyaluronate Eye Drops Distributors
- 12.2.3 Sodium Hyaluronate Eye Drops Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst